CD14 and ischemic stroke: Large-scale clinical case‒control studies [51, 52] have shown that a high concentration of plasma TMAO is positively correlated with the aggregation of proinflammatory mediators CD14+/CD16+ monocytes and the incidence of ischemic stroke, which is regarded as a predictor of poorer functional outcome events and mortality [24].